{"id":28425,"date":"2013-11-01T13:39:33","date_gmt":"2013-11-01T17:39:33","guid":{"rendered":"http:\/\/blogviejo.sld.cu\/marionod\/?p=28425"},"modified":"2013-11-01T13:39:33","modified_gmt":"2013-11-01T17:39:33","slug":"ontario-guidelines-for-treatment-of-gaucher-disease-by-enzyme-replacement-with-imiglucerase-or-velaglucerase-or-substrate-reduction-therapy-with-miglustat-version-9-august-2011","status":"publish","type":"post","link":"https:\/\/blogs.sld.cu\/marionod\/2013\/11\/01\/ontario-guidelines-for-treatment-of-gaucher-disease-by-enzyme-replacement-with-imiglucerase-or-velaglucerase-or-substrate-reduction-therapy-with-miglustat-version-9-august-2011\/","title":{"rendered":"ONTARIO GUIDELINES FOR TREATMENT OF GAUCHER DISEASE BY ENZYME REPLACEMENT WITH IMIGLUCERASE OR VELAGLUCERASE, OR SUBSTRATE REDUCTION THERAPY WITH MIGLUSTAT (Version 9; August 2011)"},"content":{"rendered":"<p><a href=\"http:\/\/www.garrod.ca\/wp-content\/uploads\/ONTARIO-GUIDELINES-FOR-TREATMENT-OF-GAUCHER-August-2011-2.pdf\" target=\"_blank\">ONTARIO GUIDELINES FOR TREATMENT OF GAUCHER DISEASE BY ENZYME REPLACEMENT WITH IMIGLUCERASE OR<br \/>\nVELAGLUCERASE, OR SUBSTRATE REDUCTION THERAPY WITH MIGLUSTAT (Version 9; August 2011)<\/a><\/p>\n<p>La enfermedad de Gaucher (EG) es una enfermedad hereditaria rara, causada por la deficiencia de la enzima glucocerebrosidasa (GCasa), que se requiere para la descomposici\u00f3n de un l\u00edpido especializado, llamado glucocerebrosidasa, que se produce en todo el cuerpo, pero particularmente en el h\u00edgado, el bazo y la m\u00e9dula \u00f3sea. El objetivo de estas directrices es ayudar a la elegibilidad para el tratamiento y el tratamiento modalidad. La decisi\u00f3n de tratar se basar\u00e1 en los criterios que se describen a continuaci\u00f3n. La elecci\u00f3n de modalidad se basar\u00e1 en<\/p>\n<p>\u2022 recomendaci\u00f3n de un m\u00e9dico con experiencia en el tratamiento de la GD<br \/>\n\u2022 la preferencia del paciente<br \/>\n\u2022 La consideraci\u00f3n cl\u00ednica y financiera.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>ONTARIO GUIDELINES FOR TREATMENT OF GAUCHER DISEASE BY ENZYME REPLACEMENT WITH IMIGLUCERASE OR VELAGLUCERASE, OR SUBSTRATE REDUCTION THERAPY WITH MIGLUSTAT (Version 9; August 2011) La enfermedad de Gaucher (EG) es una enfermedad hereditaria rara, causada por la deficiencia de la enzima glucocerebrosidasa (GCasa), que se requiere para la descomposici\u00f3n de un l\u00edpido especializado, llamado glucocerebrosidasa, [&hellip;]<\/p>\n","protected":false},"author":126,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[1615,1533,64,19,283,4],"tags":[],"_links":{"self":[{"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/posts\/28425"}],"collection":[{"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/users\/126"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/comments?post=28425"}],"version-history":[{"count":0,"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/posts\/28425\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/media?parent=28425"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/categories?post=28425"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/tags?post=28425"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}